Dr. Perlis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
15 Parkman Street Wac 812
Psychiatry Outpatient Department
Boston, MA 02114Phone+1 617-724-5600Fax+1 617-724-3028
Education & Training
- Massachusetts General Hospital/McLean HospitalResidency, Psychiatry, 1997 - 2001
- Massachusetts General HospitalInternship, Internal Medicine, 1997 - 1998
- Harvard Medical SchoolClass of 1997
Certifications & Licensure
- MA State Medical License 1998 - 2026
- American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- Effectiveness of Pramipexole for Treatment-Resistant Depression Start of enrollment: 2003 Sep 01
- Simvastatin Augmentation of Lithium Treatment in Bipolar Depression Start of enrollment: 2012 Aug 01
- Adjunctive Isradipine for the Treatment of Bipolar Depression Start of enrollment: 2013 Feb 01
Publications & Presentations
PubMed
- 100 citationsAkathisia: an updated review focusing on second-generation antipsychotics.John M. Kane, W. Wolfgang Fleischhacker, Lars K. Hansen, Roy H. Perlis, Andrei Pikalov
The Journal of Clinical Psychiatry. 2009-04-21 - 196 citationsIndustry sponsorship and financial conflict of interest in the reporting of clinical trials in psychiatry.Roy H. Perlis, Clifford S. Perlis, Yelena P. Wu, Cindy Hwang, Megan Joseph
The American Journal of Psychiatry. 2005-10-01 - 15 citationsAssessment of Time-Series Machine Learning Methods for Forecasting Hospital Discharge Volume.Thomas H. McCoy, Amelia M. Pellegrini, Roy H. Perlis
JAMA Network Open. 2018-11-02
Journal Articles
- Psychiatry and COVID-19Roy Perlis, Donald Goff, JAMA
- Can Electronic Health Records Revive Central Nervous System Clinical Trials?Maurizio Fava, Roy H Perlis, Nature
- Temporal Trends and Characteristics of Reportable Health Data Breaches, 2010-2017Roy Perlis, MD, JAMA
Lectures
- Effect of Cytochrome CYP2C19 Metabolizing Activity on Antidepressant Response and Side Effects: Meta-Analysis of Data from Genome-Wide Association Studies162nd Annual Meeting, San Francisco, California, USA
- Discovery of a Highly Selective Glycogen Synthase Kinase‐3 Inhibitor (PF‐04802367) That Modulates Tau Phosphorylation in the Brain: Translation for PET NeuroimagingAmerican Psychiatric Association, 162nd Annual Meeting, San Francisco, California, USA
Authored Content
- The Time Has Come for Over-the-Counter AntidepressantsApril 2024
- Genome-Wide Association Study of Dimensional Psychopathology Using Electronic Health RecordsFebruary 2018
- High Throughput Phenotyping for Dimensional Psychopathology in Electronic Health RecordsFebruary 2018
Press Mentions
- What Happens When AI Is Used to Recommend Treatments for Patients with Bipolar Disorder?September 16th, 2024
- Trust in Physicians and Hospitals During the COVID-19 Pandemic in a 50-State Survey of US AdultsAugust 26th, 2024
- Benchmarks: Mass General Research News and Notes for August 9, 2024August 9th, 2024
- Join now to see all
Grant Support
- In Vitro And In Vivo Study Of Simvastatin PLUS Lithium In Bipolar DepressionNational Institute Of Mental Health2012
- Building A Risk Stratification Model For Treatment Resistance In Major DepressiveNational Institute Of Mental Health2009–2011
- Pramipexole In Treatment-Resistant DepressionNational Institute Of Mental Health2003–2007
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: